O'Brien P Q, Fischer A B, Johnson M A. "一种替诺福韦酯杂质138的合成方法" [P]. US Patent, US 10944250 B2, 2023-08-23.
发明人陈志强,罗永刚,沈红梅. "Method for the Synthesis of Tenofovir disoproxil Impurity 138" [P]. 中国发明专利, 专利号 CN 110627991 A, 授权公告日 2021-12-09.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 替诺福韦酯杂质138 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2024, 532, 3660-3674.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替诺福韦酯杂质138 as an Impurity". J. Chromatogr. A, 2021, 1573, 3581-3605.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Tenofovir disoproxil Impurity 138 Using HRMS and NMR". Chromatographia, 2013, 227, (10), 3588-3601.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 替诺福韦酯杂质138 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2017, 1682, 6365-6381.